HHS proposed changes that would roll back many Biden-era policies, eliminate most health tech certification criteria,and ...

Between the massive cyberattack on Optum’s Change Healthcare unit and the recent attack on St. Louis-based health system Ascension, it seems like there is a new healthcare cybersecurity incident each ...

In the wake of the news that HealthSpot has ceased operations, the kiosk-based telehealth service provider is remaining mum, but others in the industry remain bullish on video consults. So far, ...

Epic is welcoming generative AI’s entrance into healthcare. The company is expanding its existing collaboration with Microsoft by integrating OpenAI services, such as GPT-4, into its EHR. The partners ...

A new Supernus Pharmaceuticals medical device that continuously administers an old Parkinson’s disease drug is now FDA approved, giving patients another way to manage the motor control symptoms that ...

Eli Lilly announced a partnership with Walmart on Wednesday to expand access to its GLP-1 Zepbound through LillyDirect, marking LillyDirect’s first retail collaboration. LillyDirect is Eli Lilly’s ...

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment, ...

Noom, a digital health company for chronic disease prevention, will begin offering oral medications for weight loss through its Noom Med program, it announced Thursday. New York City-based Noom helps ...

“We are fundamentally trying to change how the U.S. healthcare industry interacts with provider data.” That was the lofty goal that Anshul Rathi, founder and CEO of provider intelligence platform ...

Morgan Health made a $25 million investment in Merative, a data, analytics and technology provider, the companies announced Tuesday. Washington, D.C.-based Morgan Health is a JPMorgan Chase business ...

Schizophrenia is currently treated with older medications with limited efficacy and troublesome side effects that lead many patients to stop taking them. The FDA has approved a novel Bristol Myers ...

New research emerged this month shining light on the need for wider use of continuous glucose monitors (CGMs). The study — which was conducted by CCS, a chronic care management company — analyzed data ...